Quantification of curricular content devoted to point-of- care testing for infectious diseases in schools and colleges of pharmacy in the United States


  • Vanthida Huang Midwestern University College of Pharmacy-Glendale,
  • Michael E Ferris State University College of Pharmacy
  • Paul O Gubbins Missouri State University
  • Scott J Bergman Southern Illinois University Edwardsville
  • Elias B Chahine Palm Beach Atlantic University
  • Jenana Halilovic University of the Pacific Stockton
  • Levita K Hidayat Touro College of Pharmacy, New York
  • Kathryn R Matthias University of Arizona
  • Lauren D. Tesh, Lauren D. Tesh, Lauren D. Tesh, Office of Executive Programs, Division of Advisory Committee and Consultant Management


Infectious Disease, Point Of Care Tests, Pharmacy Curriculum


Background: Point of care (POC) testing for infectious diseases represents a potential pharmacy service, but how much education on these tests is included in the professional pharmacy curriculum in the United States (US) is unknown. The aim of this study was to determine the extent to which schools/colleges of pharmacy include such content in their curriculum.

Methods: From August 2012 through June 2013, administrators from 128 schools/colleges of pharmacy were asked to complete an electronic survey.

Results: Complete responses were received from 114 (89.1%) unique institutions. One third (n=38) of responding institutions reported including such content, but the majority (94.7%) of these institutions devoted less than 3 hours to the topic in their curriculum.

Conclusions: United States professional pharmacy programs include little or no educational content regarding POC tests for infectious diseases. Academic pharmacy should explore ways to incorporate practical content regarding POC tests for infectious diseases into the professional curriculum. 

Author Biographies

Vanthida Huang, Midwestern University College of Pharmacy-Glendale,

Associate Professor, Pharmacy Practice

Michael E, Ferris State University College of Pharmacy

Professor of Pharmacy

Paul O Gubbins, Missouri State University

Associate Dean, School of Pharmacy, Vice-Chair of the Division of Pharmacy Practice and Administration

Scott J Bergman, Southern Illinois University Edwardsville

Associate Professor, Pharmacy Practice, School of Pharmacy 

Elias B Chahine, Palm Beach Atlantic University

Associate Professor, Pharmacy Practice, Lloyd L. Gregory School of Pharmacy

Jenana Halilovic, University of the Pacific Stockton

Assistant Professor, Pharmacy Practice, Thomas J Long School of Pharmacy and Health Sciences

Levita K Hidayat, Touro College of Pharmacy, New York

Assistant Professor, Pharmacy and Health Outcomes

Kathryn R Matthias, University of Arizona

Assistant Professor, Pharmacy Practice and Science, College of Pharmacy

Lauren D. Tesh, Lauren D. Tesh, Lauren D. Tesh,, Office of Executive Programs, Division of Advisory Committee and Consultant Management

Designated Federal Officer Food and Drug Administration (FDA, Center for Drug Evaluation and Research 


Brackett, P.D., Byrd, D.C., Duke, L.J., Fetterman, J.W., Unterwagner, W.L., Staton, A.G, Miller, M.S., Sheffield, M.C., Kennedy, W.K., McDuffie, C.H., Stevenson, T.L., Thompson, P.A. & McCullough, E.S. (2009). Barriers to expanding advanced practice experience site availability in an experiential consortium. American Journal of Pharmaceutical Education, 73, Article 82.

Center for Disease Control and Prevention (2005). “Good laboratory practices for waived testing sites; survey findings from testing sites holding a certificate of waiver under the Clinical Laboratory Improvement Amendment of 1988 and Recommendations for Promoting Quality Testing”. Morbidity and Mortality Weekly Report, vol. 54, no. RR-13, 1-22.

Crawford, N.D., Blaney, S., Amesty, S., Rivera, A.V., Turner, A.K., Ompad, D.C. & Fuller, C.M. (2011). Individual- and neighborhood-level characteristics associated with support of in-pharmacy vaccination amongESAP-registeredpharmacies: pharmacists’rolein reducing racial/ethnic disparities in influenza vaccinations in New York City. Journal of Urban Health, 88, 176-85.

da Camara, C.C., D’Elia, R.P. & Swanson, L.N. (1996). Survey of physical assessment course offerings in American Colleges of pharmacy. American Journal of Pharmaceutical Education, 60, 343-7.

Davies, J., Gordon, C.L., Tong, S.Y., Baird, R.W. & Davis, J.S. (2012). Impact of results of a rapid Staphylococcus aureus diagnostic test on prescribing of antibiotics for patients with cluster Gram-positive cocci in blood cultures. Journal of Clinical Microbiology, 50, 2056-58.

POC ID testing in U.S. pharmacy programs 5

Freed, S., Klepser, M., Klepser, D., Hagerman, J. & Valente, C. (2011). Assessment of the curricular content devoted to the application and interpretation of rapid diagnostic tests in colleges of pharmacy in the United States. Pharmacy Education, 11, 204-7.

Giberson, S., Yoder, S. & Lee, M.P. (2011), Improving patient and health system outcomes through advanced pharmacy practice. A report to the U.S. Surgeon General. Office of the Chief Pharmacist. U.S. Public Health Service. Rockville, MD.

Greer, A.L. & Schanzer, D. (2013). Using a dynamic model to consider optimal antiviral stockpile size in the face of pandemic influenza uncertainty. PLoS One, 8, e67253, 1-9.

Heath, D., Klepser, M. & Loftus, S. (2013). Pharmacist- managed program for the prevention and control of influenza outbreaks. Michigan Pharmacist, 51, 27-9.

Jungnickel, P.W., Kelley, K.W., Hammer, D.P., Haines, S.T. & Marlowe, K.F. (2009). Addressing competencies for the future in the professional curriculum. American Journal of Pharmaceutical Education, 73,Article 156.

Klepser, D.G. & Klepser, M.E. (2012). Cost-effectiveness of pharmacist provided treatment of adult pharyngitis. American Journal of Managed Care, 18, e145-e154.

Klepser, M. (2012). Rapid diagnostic testing in the outpatient pharmacy. Pharmacy Purchasing and Products. (online). Available at: http://www. pppmag.com/article/1143/june_2012/rapid_diagnostic_testing_in_the_outpatient_pharmacy/. Accessed 9th August, 2013.

Loubiere, S. & Moatti, J.P. (2010). Economic evaluation of point-of-care diagnostic technologies for infectious diseases. Clinical Microbiology and Infection, 16, 1070-6.

National Association of Chain Drug Stores (2011). NACDS 2011-2012 chain pharmacy industry profile. National Association of Chain Drug Stores, Alexandria, VA.

NACDS Drug Store News Briefing Document RxIMPACT (2013). Community pharmacy fills gaps in access and affordability for patients, payers (online). Available at: http://www.rxim pact.nacds.org/pdfs/ rximpact_0313.pdf. Accessed 9th August, 2013.

NACDS Foundation-NCPA-ACPE Joint Task Force (2012) Entry-level competencies needed for community pharmacy practice (online). Available at: https:// www.acpe accredit.org/ pdf/NACDSFoundation-NCPA- ACPETaskForce 2012.pdf. Accessed 9th August, 2013.

National Community Pharmacists Association (2012). NCPA Digest In-Brief (online). Available at: http:// www.ncpanet.org/pdf/digest/2012/ 2012_digest_ inbrief.pdf. Accessed 9th August, 2013.

Spray, J.W. & Parnapy, S.A. (2007). Teaching patient assessment skills to doctor of pharmacy students: The TOPAS study. American Journal of Pharmaceutical Education, 71, Article 64.

Wang, J., Ford, L.J., Wingate, L., Uroza, S.F., Jaber, N., Smith, C.T., Randolph, R., Lane, S. & Foster, S.L. (2013). Effect of pharmacist intervention on herpes zoster vaccination in community pharmacies. Journal of the American Pharmaceutical Association, 53, 46-53.





Research Article